Australia markets closed

Soleno Therapeutics, Inc. (SLNO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.1840+0.0046 (+2.56%)
At close: 04:00PM EDT
0.1800 -0.00 (-2.17%)
After hours: 07:33PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.1794
Open0.1887
Bid0.1800 x 1000
Ask0.1880 x 3200
Day's range0.1700 - 0.1940
52-week range0.1300 - 1.6700
Volume584,573
Avg. volume779,179
Market cap22.096M
Beta (5Y monthly)0.41
PE ratio (TTM)N/A
EPS (TTM)-0.3470
Earnings date26 July 2022 - 01 Aug 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est5.00
  • GlobeNewswire

    Soleno Therapeutics Announces Presentations at the 2022 European Congress of Endocrinology

    REDWOOD CITY, Calif., May 19, 2022 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (β€œSoleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced presentations at the upcoming 2022 European Congress of Endocrinology (ECE), which is being held May 21-24, 2022, in Milan, Italy. Details of the presentations are as follows: 2022 European Congress of Endocrinology (ECE) Title:DCCR UpdateFormat:Presentation at the I

  • Zacks

    KemPharm (KMPH) Stock Up on Deal to Acquire Orphazyme for $12.8M

    KemPharm (KMPH) inks deal to acquire Orphazyme A/S, which will add to its portfolio the latter's pipeline candidate, arimoclomol, being developed for treating Niemann-Pick disease type C. Shares rise.

  • GlobeNewswire

    Soleno Therapeutics to Participate in the H.C. Wainwright Global Investment Conference

    REDWOOD CITY, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (β€œSoleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that Anish Bhatnagar, M.D., Chief Executive Officer, will present a corporate overview at the H.C. Wainwright Global Investment Conference, being held May 23-26, 2022, virtually and in Miami, FL. The presentation will be available on-demand beginning at 7 AM Eastern